Kevin Kavanagh, MD, MS
June 9, 2023
Public Comment: CDC HICPAC Meeting –
Enhanced Barrier Precautions.
Enhanced barrier precautions is advocated for use to mitigate
the spread of CRE and C. Auris. These are highly dangerous organisms. A
clinical trial is certainly indicated before planning for adoption in
non-research settings. A better approach is screening to identify the
microbiome of residents, decolonization and cohorting if decolonization
is not successful. It is concerning that the CDC appears to be moving
forward with EBP where there is little evidence supporting their
effectiveness with dangerous pathogens and also appears to be
considering abandoning N95 masking where there is decades of
occupational research supporting their use. Control Practices Advisory
Committee (HICPAC), June 9, 2023.
View Written Comment: https://www.healthwatchusa.org/HWUSA-Presentations-Community/PDF-Downloads/20230609-CDC-Public-Comment.pdf
YouTube Video:
https://youtu.be/RiFQAaPEHPE
Health Watch USAsm Public Comment June 9, 2023.
All information contained on this website is the express opinion /span> strong>
of the presentor and not necessarily that of
Health Watch USA Inc. a Kentucky Non-Profit Organization
The Video Above is a Health Watch USAsm Video.
Health Watch USA is a non-profit 501-C3 Organization based in Kentucky